Resultado da Busca
Related 23andMe Biotechnology Biology Natural science Science forward back. r/23andme. r/23andme. Talk about your genes and their possible implications!
Há 1 dia · 0. ME. -1,28%. Lundi, Citi a maintenu sa position neutre sur 23andMe Holding (NASDAQ:ME), avec un objectif de prix stable de 0,63 $. La décision intervient après que la société de biotechnologie a présenté des données préliminaires de phase 2 lors de la réunion de la Société américaine d'oncologie clinique (ASCO) de 2024.
Há 7 horas · Join SI Premium – FREE. Citi analyst Daniel Grosslight reiterated a Neutral rating and $0.63 price target on 23andMe Holding (NASDAQ: ME ). The analyst comments "At the 2024 American Society of ...
Há 1 dia · As 23andMe (NASDAQ:ME) continues to make strides in the development of its experimental drug 23ME-00610, investors are keeping a close eye on the company's financial health and market performance. According to the latest InvestingPro data, 23andMe has a market capitalization of $267.29 million.
Há 1 dia · U.S. District Judge Edward Chen heard arguments on Monday from more than a dozen lawyers vying for leadership of the 23andMe data breach litigation. Monday's hearing, in San Francisco, comes after ...
Há 1 dia · 2024-06-03 19:42. On Monday, Citi maintained its Neutral rating on 23andMe Holding ( NASDAQ :ME), with a steady price target of $0.63. The decision comes after the biotechnology company presented early Phase 2 data at the 2024 American Society of Clinical Oncology (ASCO) meeting. The data pertained to its ongoing Phase 1/2a trial of 23ME-00610 ...
Há 1 dia · Alors que 23andMe (NASDAQ:ME) continue de progresser dans le développement de son médicament expérimental 23ME-00610, les investisseurs suivent de près la santé financière de la société et ses performances boursières. Selon les dernières données d'InvestingPro, 23andMe a une capitalisation boursière de 267,29 millions de dollars.
